Healthcare-associated infections (HAIs) affect approximately 1 in 31 hospitalized patients on any given day — translating to approximately 1.7 million infections and 99,000 attributable deaths annually in the U.S., according to CDC estimates. CMS has eliminated reimbursement for five preventable HAI categories (CLABSIs, CAUTIs, SSIs, MRSA bacteremia, and C. diff infections) under the Hospital-Acquired Condition (HAC) Reduction Program. Effective prevention requires supply discipline, protocol standardization, and a culture of infection prevention. Our comprehensive catalog covers every supply category relevant to HAI prevention.
CAUTI Prevention: The Foley-First Failure
Catheter-associated urinary tract infections (CAUTIs) are the most common HAI, associated with each indwelling urinary catheter day adding 3–7% daily infection risk. The CAUTI prevention bundle includes: (1) appropriate indications only (monitoring urine output in critically ill patients, obstruction, comfort in end-of-life care — not incontinence); (2) aseptic insertion technique using closed sterile drainage system; (3) maintain unobstructed dependent drainage; (4) daily assessment of catheter necessity with prompt removal. Antimicrobial-coated urinary catheters (silver-alloy, nitrofural) reduce CAUTI rates by 25–45% in high-risk patients — available in our urology catalog from Bard Medical and Rochester Medical.
VAP Prevention: Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (VAP) affects 2–16% of mechanically ventilated patients and adds 7–12 days to ICU LOS. The VAP prevention bundle: (1) elevate head of bed 30–45°; (2) daily sedation interruption and readiness-to-extubate assessment; (3) oral care with CHG (0.12% oral rinse twice daily significantly reduces oropharyngeal colonization and VAP rate); (4) subglottic secretion drainage via suction above the ETT cuff (ETTs with subglottic suction ports — Mallinckrodt SealGuard, Covidien TaperGuard — reduce VAP by 50%); (5) closed suctioning systems to minimize circuit contamination. CHG oral care products and subglottic suction ETTs from our respiratory section are available in bulk for ICU use.
MRSA Prevention: Beyond Contact Precautions
MRSA decolonization using intranasal mupirocin 2% ointment combined with CHG bathing for 5 days has demonstrated 40–70% MRSA surgical site infection reduction in high-risk patients (total joint arthroplasty, cardiac surgery). Universal ICU decolonization (daily CHG bathing of all ICU patients regardless of MRSA status) reduced MRSA clinical culture rates by 37% and bloodstream infections by 44% in the landmark REDUCE MRSA trial (NEJM 2013). CHG bathing cloths, mupirocin nasal ointment, and CHG body wash are all available in our skin care section. Contact precautions supplies including isolation gowns and gloves are in our PPE catalog.
C. diff Prevention: Environmental Decontamination
Clostridioides difficile spores survive environmental surfaces for months and are resistant to standard quaternary ammonium disinfectants — requiring sodium hypochlorite (bleach, 1,000–5,000 ppm) or hydrogen peroxide vapor (HPV) for adequate environmental decontamination. Sporicidal wipes and solutions for C. diff contact precaution rooms, dedicated equipment, and terminal room cleaning are essential supply elements. Patient placement in private rooms with dedicated toilet facilities, hand hygiene with soap and water (alcohol-based hand rub does not eliminate C. diff spores), and contact precautions for the duration of illness are CDC-required measures.
